Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine and IV Fluid for Orthostatic Hypotension after THA
NCT02154243Terminated
- Sponsor
- Hospital for Special Surgery
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midodrine in orthostatic hypotension (OH) (3 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Change in Orthostatic Hypotension Questionnaire Score. Started Jun 2014; status: terminated.
02
Drugs
midodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT02154243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154243.